2021
DOI: 10.1016/j.bmc.2021.116055
|View full text |Cite
|
Sign up to set email alerts
|

Small molecule inhibitor E-64 exhibiting the activity against African swine fever virus pS273R

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 31 publications
0
8
0
Order By: Relevance
“…Its complex viral structure and unexplained infection mechanisms have greatly hindered the development of vaccines and specific antiviral drugs. Several anti-ASFV small molecule compounds were synthesized and evaluated, for example, the ASFV pS273R inhibitor E-64 and microtubule-stabilizing agent compound 6b [29,30]. However, the ASFV encodes 68 structural proteins and more than 100 non-structural proteins and regulates multiple cellular biological processes to finish its life-cycle [31].…”
Section: Discussionmentioning
confidence: 99%
“…Its complex viral structure and unexplained infection mechanisms have greatly hindered the development of vaccines and specific antiviral drugs. Several anti-ASFV small molecule compounds were synthesized and evaluated, for example, the ASFV pS273R inhibitor E-64 and microtubule-stabilizing agent compound 6b [29,30]. However, the ASFV encodes 68 structural proteins and more than 100 non-structural proteins and regulates multiple cellular biological processes to finish its life-cycle [31].…”
Section: Discussionmentioning
confidence: 99%
“…The structural differences between pS273R and other proteases make pS273R an attractive target for the development of drugs against ASFV. Indeed, previous work has shown that reduced expression of pS273R inhibited polyprotein processing, and significantly reduced infectious virus production [ 6 , 7 , 8 ]. In addition, researchers have found that gasdermin D (GSDMD) can also be cut by ASFV pS273R.…”
Section: Introductionmentioning
confidence: 99%
“…Despite ongoing efforts, there are currently no effective drugs for the treatment of ASF, several molecules have been identified as having inhibitory activity against the pS273R protein of the ASFV. These include a group of peptide inhibitors based on the human SUMO-1 substrate complex (RCSB_PDB: 1TGZ) that contain an electrophilic warhead (-CHO), and the defensin-like peptide toxin OPTX-1 and the small molecule inhibitor E64 [ 7 , 12 ]. The peptide inhibitor taking the CHO group contains a carbonyl carbon, which is an electrophilic group capable of attracting electrons from nucleophilic groups.…”
Section: Introductionmentioning
confidence: 99%
“…Alternatively, genistein and fluoroquinolones, such as enrofloxacin, were found to impair viral genome replication by inhibiting the ASFV type II topoisomerase ( 21 23 ). Viral protease inhibitors OPTX-1 and E-64 inhibit the activity of S273R, a highly conserved ASFV protease of the SUMO-1 cysteine protease family, impairing ASFV replication ( 24 , 25 ). Other inhibitors of ASFV replication have also been described but the viral or cellular targets have not been fully defined.…”
Section: Introductionmentioning
confidence: 99%